Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
Luciferase | 6 | 0 | 0 | 6 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
hypoxia-inducible factor 1 alpha subunit | 5 | 0 | 0 | 5 |
RAR-related orphan receptor gamma | 5 | 0 | 0 | 5 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
TDP1 protein | 5 | 0 | 0 | 5 |
GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
AR protein | 6 | 0 | 0 | 6 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
progesterone receptor | 5 | 0 | 0 | 5 |
glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
polyprotein | 1 | 0 | 0 | 1 |
67.9K protein | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 4 | 0 | 0 | 4 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
caspase-3 | 1 | 0 | 0 | 1 |
IDH1 | 4 | 0 | 0 | 4 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Histone H2A.x | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 4 | 0 | 0 | 4 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
geminin | 5 | 0 | 0 | 5 |
Vif | 0 | 0 | 0 | 1 |
peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Interferon beta | 4 | 0 | 0 | 4 |
Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Methionine aminopeptidase | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 4 | 0 | 0 | 4 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
Ataxin-2 | 4 | 0 | 0 | 4 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
acetylcholinesterase | 3 | 0 | 0 | 3 |
calpain II, partial | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
envelope glycoprotein | 0 | 1 | 0 | 1 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
G | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Transthyretin | 0 | 2 | 1 | 3 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
Tyrosine-protein kinase Lck | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
Replicase polyprotein 1a | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 4 | 0 | 4 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Thromboxane-A synthase | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 4 | 0 | 4 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Pup--protein ligase | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
GABA theta subunit | 1 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
SUMO-1 | 0 | 2 | 0 | 2 |
GLS protein | 1 | 0 | 0 | 1 |
PINK1 | 3 | 0 | 0 | 3 |
Parkin | 3 | 0 | 0 | 3 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
small ubiquitin-related modifier 2 isoform b precursor | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
Alpha-synuclein | 2 | 0 | 0 | 2 |
TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Smad3 | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
glucose-6-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
TSHR protein | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
hexokinase | 0 | 1 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 2 | 2 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Long-chain-fatty-acid--AMP ligase FadD32 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Sporulation initiation phosphotransferase F | 0 | 1 | 0 | 1 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Sporulation kinase A | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Chitinase | 0 | 2 | 0 | 2 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
hepatitis C virus polyprotein | 1 | 0 | 0 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Cruzipain | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |